Home > News > Nanotech Puts Cancer In The Cross Hairs
February 22nd, 2008
Nanotech Puts Cancer In The Cross Hairs
Abstract:
Unfortunately, when it comes to treating cancer, modern medicine is still in its infancy. By and large, we still rely on debilitating chemotherapy regimens which take a shotgun approach to curing cancer by essentially poisoning patients in an effort to eradicate tumors.
But nanotech represents a bright spot in the fight against cancer. Researchers are increasingly turning to new, innovative therapies, based on particles measuring less than 200 nanometers. At that scale, particles passively target weaker-walled cancer cells and help localize treatment, increasing its effectiveness while minimizing damage to healthy tissue.
The medication Doxil, produced by Ortho Biotech Products LP--a unit of Johnson & Johnson (nyse: JNJ - news - people )--uses this approach to treat certain myeloma and ovarian cancers. It incorporates chemotherapy into 100-nm liposome particles that circulate through the blood over long periods and slip into the pores of tumor blood vessels, helping to concentrate treatment at the disease site.
Source:
forbes.com
Related News Press |
News and information
Researchers develop artificial building blocks of life March 8th, 2024
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Researchers develop artificial building blocks of life March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||